Alkem Laboratories Limited

₹5,304As of Sun 8 Nov 2026, 12:00 UTC
NSE:ALKEMHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 13.38%
Div yield 1.00%
ROE 17.56%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.29
PE TTM 29.39
TSR TTM (2.73%)
Mkt cap ₹634.2B
ROIC 16.29%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹5,621
5.98%
(42.73%)
Hold 12|0|4|8|9
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
63.63
71.10
71.99
76.25
(0.38%)
15.65%
21.88%
26.52%
Revenue₹B
41.81
40.76
42.42
43.89
4.84%
(2.72%)
(0.56%)
3.06%
Peers (US$6.744B)
Cap (US$)
PE
5.968B
33.91x
5.568B
42.33x
Capital
TTM
5Y
10Y
Leveragex
2.447
—
—
EBIT/Intx
0.356
0.204
0.235
Own earn%
21.59
36.08
37.84
Sh yield%
50.52
57.04
55.81
Owners
Insiders/Inst%
9.56
59.30
Short interest%
1.22
SBC / revenue%
0.31
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
27–32
$1 testx
0.0
Incr. ROIC%
2